跳至主要内容
临床试验/ISRCTN18383298
ISRCTN18383298已完成未知

Multicentre, randomised, open clinical trial to assess the efficacy of an intervention to reduce the cardiovascular risk by improving the information given to patients at high cardiovascular risk

Biomedical Research Institute Sant Pau0 个研究点目标入组 464 人开始时间: 2018年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
464

研究概览

简要总结

2021 results in https://pubmed.ncbi.nlm.nih.gov/33807285/ (added 17/06/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both gender
  • 2. 40- 69 years old
  • 3. Fulfilling at least one of the following criteria
  • 3.1. High cardiovascular risk (SCORE =5% and/or REGICOR =10%)
  • 3.2. SCORE relative risk >= 4
  • 3.3. Diabetes with proteinuria or a major risk factor (smoking, dyslipidaemia or hypertension)
  • 4. Severe kidney chronic disease (GFR < 30 mL/min/1.73 m2)
  • 5. Subclinical Atherosclerosis

排除标准

  • 1. Patients with established cardiovascular disease
  • 2. Life expectancy of less than 1 year
  • 3. Mental disease limiting patient’s self-care capability
  • 4. Drug and/or alcohol abuse
  • 5. Already enrolled in another clinical trial

研究者

发起方
Biomedical Research Institute Sant Pau

相似试验